FoodNov 26, 2025
Haitai Cinnamon Powder recall — FDA H-0203-2026
Elevated levels of lead in Cinnamon powder.
Class IIFDA: OngoingHaitai, Inc.
Monthly breakdown
2025 recalls by month
Select a month to review the recall records reported during that period.
December 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025285 records · 4 categoriesAugust 2025239 records · 4 categoriesJuly 2025370 records · 4 categoriesJune 2025342 records · 4 categoriesMay 2025258 records · 4 categoriesApril 2025302 records · 4 categoriesMarch 2025259 records · 4 categoriesFebruary 2025260 records · 4 categoriesJanuary 2025354 records · 4 categories
2025 recalls — page 20
Records are ordered by the best available source date.
FoodNov 26, 2025
Twin Sisters Creamery 3lb recall — FDA H-0194-2026
Raw milk Farmhouse cheeses are recalled due to E. coli O103:H2 and E. coli O74:H25.
Class IFDA: TerminatedTwin Sisters Creamery, LLC
FoodNov 26, 2025
Twin Sisters Creamery 3lb recall — FDA H-0196-2026
Raw milk Mustard Seed cheese is recalled due to E. coli O103:H2 and E. coli O74:H25.
Class IFDA: TerminatedTwin Sisters Creamery, LLC
FoodNov 26, 2025
Peterson Company Item# 29608 Farmhouse White, Twin Sisters Creamery brand recall — FDA H-0198-2026
Item #29608 Farmhouse White is recalled due to E. coli O103:H2.
Class IFDA: TerminatedPeterson Company Inc
FoodNov 26, 2025
Twin Sisters Creamery 2.5lb recall — FDA H-0193-2026
Raw milk Whatcom Blue cheese is recalled due to E. coli O103:H2.
Class IFDA: TerminatedTwin Sisters Creamery, LLC
DrugNov 26, 2025
DermaRite Industries DermaCerin, Skin Protectant Moisturizing Cream (petrolatum 33%) recall — FDA D-0161-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
DrugNov 26, 2025
Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle recall — FDA D-0156-2026
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
Class IIIFDA: OngoingAlembic Pharmaceuticals Limited
DrugNov 26, 2025
DermaRite Industries 4-N-1 Skin Protectant, No Rinse Wash Cream with Dimethicone 1%, 113g recall — FDA D-0160-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
DrugNov 26, 2025
SKIN PROTECTANT WITH LANOLIN McKesson Skin Protectant, Lanolin USP recall — FDA D-0171-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
DrugNov 26, 2025
Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle recall — FDA D-0159-2026
Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules.
Class IIFDA: OngoingZydus Pharmaceuticals (USA) Inc
DrugNov 26, 2025
DermaRite Industries Lantiseptic, Dry Skin Therapy, Lanolin USP 30% recall — FDA D-0169-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
DrugNov 26, 2025
DermaRite Industries Renew Skin Repair Cream, Dimethicone 1.5% recall — FDA D-0175-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
DrugNov 26, 2025
Park Avenue Compounding Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII recall — FDA D-0178-2026
CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
Class IIFDA: OngoingPark Avenue Compounding
DrugNov 26, 2025
POTASSIUM CHLORIDE Inj., 20 mEq total in 50 mL Flexible Container, Highly concentrated 400 recall — FDA D-0180-2026
Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq
Class IFDA: OngoingOtsuka ICU Medical LLC
DrugNov 26, 2025
DermaRite Industries Hand-E-Foam, Benzethonium Chloride 0.20% recall — FDA D-0167-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
DrugNov 26, 2025
DermaRite Industries GelRite Instant Hand Sanitizer, Alcohol 65% recall — FDA D-0166-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
DrugNov 26, 2025
DermaRite Industries UltraSure Anti-Perspirant & Deodorant, Aluminum Sesquichlorohydrate recall — FDA D-0177-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
DrugNov 26, 2025
POTASSIUM CHLORIDE Inj., 10 mEq total in 100 mL Flexible Container, Highly concentrated 100 recall — FDA D-0181-2026
Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq
Class IFDA: OngoingOtsuka ICU Medical LLC
DrugNov 26, 2025
DermaRite Industries San-E-Foam, Alcohol 67%, 1000 mL (34 fl. oz.) per cartridge, DermaRite recall — FDA D-0176-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
DrugNov 26, 2025
DermaRite Industries DermaKleen, Health Care Antiseptic Lotion Soap with Vitamin E recall — FDA D-0163-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
DrugNov 26, 2025
NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle recall — FDA D-0158-2026
Failed Dissolution Specifications
Class IIFDA: OngoingGolden State Medical Supply Inc.
DrugNov 26, 2025
DermaRite Industries Renew PeriProtect, Zinc Oxide 12%, Dimethicone 1%, 113g (4 oz.) per recall — FDA D-0174-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
DrugNov 26, 2025
DermaRite Industries PeriGuard Ointment, Petrolatum 49.9% recall — FDA D-0173-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
DrugNov 26, 2025
DermaRite Industries DermaMed Ointment, Skin Protectant, Aluminum Hydroxide Gel 2%, Net Wt. recall — FDA D-0164-2026
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Class IIFDA: OngoingDermaRite Industries, LLC
About the 2025 recall archive
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.